Preventing Staphylococcus aureus infection during chronic peritoneal dialysis

Area of Science:

• Nephrology
• Infectious Diseases
• Clinical Microbiology

Background:

• Chronic peritoneal dialysis is susceptible to infections, particularly peritonitis.
• Staphylococcus aureus is a common pathogen in peritonitis, often linked to exit site colonization.
• Understanding bacterial epidemiology is crucial for preventing dialysis-related infections.

Purpose of the Study:

• To investigate the bacterial epidemiology of peritonitis in chronic peritoneal dialysis patients.
• To evaluate the efficacy of antibiotic prophylaxis in preventing peritonitis, specifically Staphylococcus aureus infections.

Main Methods:

• Prospective evaluation of catheter exit site cultures in patients with acute peritonitis over 18 months.
• Randomized, controlled trial of long-term antibiotic prophylaxis with trimethoprim-sulfamethoxazole in new peritoneal dialysis patients over 2 years.

Main Results:

• Staphylococcus aureus peritonitis was significantly associated with S. aureus at the exit site (85% of cases).
• Antibiotic prophylaxis with trimethoprim-sulfamethoxazole reduced the incidence of S. aureus peritonitis (2/28 treated vs. 11/37 untreated).
• Prophylaxis showed the most significant effect during the first 3 months of therapy.

Conclusions:

• Staphylococcus aureus exit site infections are strong predictors of S. aureus peritonitis in peritoneal dialysis.
• Long-term antibiotic prophylaxis, particularly trimethoprim-sulfamethoxazole, is effective in reducing S. aureus peritonitis.
• Early initiation of antibiotic prophylaxis is key for maximizing its protective effect.